BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Results 101 - 101 of 101 : « Previous 1 2 3 4 5 6

Recs

8
Member Avatar TMFCandyMountain (99.84) Submitted: 4/27/2006 1:35:17 AM : Outperform Start Price: $12.13 BMRN Score: +209.56

This company has very good products for rare genetic diseases and absolutely no competition. The company is probably worth $25 if its drug Phenoptin works. I expect it will get bought out at some point in the next few years as its pipeline is pretty thin.

Report this Post 1 Comment | Reply | Permalink
Results 101 - 101 of 101 : « Previous 1 2 3 4 5 6

Featured Broker Partners


Advertisement